Enoxaparin for thromboprophylaxis in hospitalized COVID-19 patients: The X-COVID-19 Randomized Trial

MLA

Nuccia Morici, et al. Enoxaparin for Thromboprophylaxis in Hospitalized COVID-19 Patients: The X-COVID-19 Randomized Trial. Jan. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d08fc02625071007f3b757f3d46d5a31&authtype=sso&custid=ns315887.

APA

Nuccia Morici, GianMarco Podda, Simone Birocchi, Luca Bonacchini, Marco Merli, Michele Trezzi, Gianluca Massaini, Marco Agostinis, Giulia Carioti, Francesco Saverio Serino, Gianluca Gazzaniga, Daniela Barberis, Laura Antolini, Maria Grazia Valsecchi, & Marco Cattaneo. (2022). Enoxaparin for thromboprophylaxis in hospitalized COVID-19 patients: The X-COVID-19 Randomized Trial.

Chicago

Nuccia Morici, GianMarco Podda, Simone Birocchi, Luca Bonacchini, Marco Merli, Michele Trezzi, Gianluca Massaini, et al. 2022. “Enoxaparin for Thromboprophylaxis in Hospitalized COVID-19 Patients: The X-COVID-19 Randomized Trial,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d08fc02625071007f3b757f3d46d5a31&authtype=sso&custid=ns315887.